- Yooma Wellness’ (CSE:YOOM) wholly owned subsidiary, Yooma Europe Ltd. has completed the sale of Birmingham, England-based Vitality CBD Ltd. to Psilobrain Therapeutics Inc.
- Vitality CBD was sold for a total consideration of US$2 million, split as US$1 million in cash and US$1 million in new shares of Psilobrain
- Psilobrain is a private Canadian biotech company that uses the latest in psychedelic medicine to design products that facilitate evidence-based healing and wellness
- Yooma Wellness last traded at $0.005 per share
Yooma Wellness’ (CSE:YOOM) wholly owned subsidiary, Yooma Europe Ltd. has completed the sale of Birmingham, England-based Vitality CBD Ltd.
Vitality CBD is a U.K.-focused CBD company that Yooma Europe sold for a total consideration of US$2 million to Psilobrain Therapeutics Inc. The payment will be split as US$1 million in cash and US$1 million in new shares of Psilobrain.
Psilobrain is a private Canadian biotech company that uses the latest in psychedelic medicine to design products that facilitate evidence-based healing and wellness.
Yooma Wellness is a vertically integrated wellness platform, including cannabidiol (CBD) products and other wellness brands. The company, through its Socati subsidiary, produces cannabinoid ingredients, including CBD and other minor cannabinoids.
Yooma Wellness last traded at $0.005 per share.
Join the discussion: Find out what everybody’s saying about this stock on the Yooma Wellness Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
